Noteworthily, we also test the ability of SPINK1 manipulation to alter HCC cells’ sensitivity to tyrosine kinase inhibitor sorafenib, but our data does not show it to be effective. This evidence concerns the gene SPINK1 and hepatocellular carcinoma.